Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
Rivero-Juarez A, Gonzalez R, Frias M, Manzanares-Martín B, Rodriguez-Cano D, Perez-Camacho I, Gordon A, Cuenca F, Camacho A, Pineda JA, Peña J, Rivero A. Rivero-Juarez A, et al. Among authors: rivero a. Pharmacogenomics J. 2017 Jul;17(4):360-365. doi: 10.1038/tpj.2016.19. Epub 2016 Mar 15. Pharmacogenomics J. 2017. PMID: 26975229
Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin.
Monje-Agudo P, Castro-Iglesias A, Rivero-Juárez A, Martínez-Marcos F, Ortega-González E, Real LM, Pernas B, Merchante N, Cid P, Macías J, Merino MD, Rivero A, Mena A, Neukam K, Pineda JA; Grupo de Estudio de Hepatitis Vírica, of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Monje-Agudo P, et al. Among authors: rivero a, rivero juarez a. Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):1929-36. doi: 10.1007/s10096-015-2434-6. Epub 2015 Jul 9. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26155784
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.
Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda JA, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A, Rivero A. Frías M, et al. Among authors: rivero a, rivero juarez a. Pharmacogenomics J. 2017 Dec;17(6):551-555. doi: 10.1038/tpj.2016.42. Epub 2016 May 31. Pharmacogenomics J. 2017. PMID: 27241060
HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.
Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda JA, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A, Rivero A. Frías M, et al. Among authors: rivero a, rivero juarez a. Pharmacogenomics J. 2017 Dec;17(6):479-480. doi: 10.1038/tpj.2016.80. Epub 2016 Oct 25. Pharmacogenomics J. 2017. PMID: 27779247 No abstract available.
Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.
Di Lello FA, Caruz A, Rallon NI, Rivero-Juarez A, Neukam K, Barreiro P, Camacho A, García-Rey S, Rivero A, Soriano V, Cifuentes C, Macias J, Pineda JA. Di Lello FA, et al. Among authors: rivero a, rivero juarez a. Eur J Clin Microbiol Infect Dis. 2013 Nov;32(11):1427-35. doi: 10.1007/s10096-013-1894-9. Epub 2013 May 29. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23715768
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
Mira JA, Neukam K, López-Cortés LF, Rivero-Juárez A, Téllez F, Girón-González JA, de los Santos-Gil I, Ojeda-Burgos G, Merino D, Ríos-Villegas MJ, Collado A, Torres-Cornejo A, Macías J, Rivero A, Pérez-Pérez M, Pineda JA; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI); Red de Investigación en SIDA (RIS-HEP07). Mira JA, et al. Among authors: rivero a, rivero juarez a. Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1879-84. doi: 10.1007/s10096-015-2426-6. Epub 2015 Jun 27. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26115631
Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance.
Rivero-Juarez A, Caruz A, Real LM, Martinez-Dueñas L, Marquez FJ, Frias M, Recio E, Gordon A, Pineda JA, Rivero A, Camacho A; Group for the Study of Viral Hepatitis (HEPAVIR) of the Andalusian Society of Infectious Diseases (SAEI). Rivero-Juarez A, et al. Among authors: rivero a. Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2171-5. doi: 10.1007/s10096-015-2463-1. Epub 2015 Aug 9. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26254560
657 results